Company Filing History:
Years Active: 1997-1998
Title: Innovations by Aaron Bayne Miller
Introduction
Aaron Bayne Miller is an accomplished inventor based in Sunnyvale, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for therapeutic use. With a total of 2 patents, Miller's work focuses on innovative solutions to medical challenges.
Latest Patents
Miller's latest patents include the invention of 1-phenylalkanone 5-HT.sub.4 receptor ligands. This invention relates to novel 5-HT.sub.4 receptor ligands which are 1-(5-halo-4-aminophenyl) (C.sub.2-6)alkan-1-one derivatives. These derivatives are designed to be substituted at specific positions to enhance their pharmacological properties. Another significant patent involves pyrrole pyridazine and pyridazinone anti-inflammatory agents. These compounds are described as useful in treating inflammation and pain, showcasing Miller's commitment to addressing critical health issues.
Career Highlights
Aaron Bayne Miller is currently employed at Syntex (U.S.A.) Inc., where he continues to innovate and develop new pharmaceutical compounds. His work has been instrumental in advancing the company's research initiatives and product offerings.
Collaborations
Miller has collaborated with notable colleagues, including James Patrick Dunn and Chakk S Ramesha. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Aaron Bayne Miller's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare solutions. His work continues to impact the industry positively, paving the way for future advancements.